VROOM INC (VRM)

US92918V2088 - Common Stock

12.84  +0.35 (+2.8%)

Premarket: 13.5 +0.66 (+5.14%)

Fundamental Rating

2

Overall VRM gets a fundamental rating of 2 out of 10. We evaluated VRM against 126 industry peers in the Specialty Retail industry. VRM may be in some trouble as it scores bad on both profitability and health. VRM is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

VRM had negative earnings in the past year.
VRM had a negative operating cash flow in the past year.
VRM had negative earnings in each of the past 5 years.
In the past 5 years VRM always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -24.77%, VRM is doing worse than 86.51% of the companies in the same industry.
Looking at the Return On Equity, with a value of -299.24%, VRM is doing worse than 81.75% of the companies in the same industry.
Industry RankSector Rank
ROA -24.77%
ROE -299.24%
ROIC N/A
ROA(3y)-22.79%
ROA(5y)-25.81%
ROE(3y)-144.96%
ROE(5y)-108.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

VRM has a Gross Margin of 18.13%. This is amonst the worse of the industry: VRM underperforms 83.33% of its industry peers.
VRM's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for VRM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y51%
GM growth 5Y20.6%

2

2. Health

2.1 Basic Checks

VRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VRM has less shares outstanding
Compared to 5 years ago, VRM has less shares outstanding
Compared to 1 year ago, VRM has a worse debt to assets ratio.

2.2 Solvency

VRM has an Altman-Z score of -1.67. This is a bad value and indicates that VRM is not financially healthy and even has some risk of bankruptcy.
VRM's Altman-Z score of -1.67 is on the low side compared to the rest of the industry. VRM is outperformed by 90.48% of its industry peers.
A Debt/Equity ratio of 3.72 is on the high side and indicates that VRM has dependencies on debt financing.
The Debt to Equity ratio of VRM (3.72) is worse than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.72
Debt/FCF N/A
Altman-Z -1.67
ROIC/WACCN/A
WACC6.53%

2.3 Liquidity

A Current Ratio of 1.11 indicates that VRM should not have too much problems paying its short term obligations.
The Current ratio of VRM (1.11) is worse than 75.40% of its industry peers.
A Quick Ratio of 0.92 indicates that VRM may have some problems paying its short term obligations.
VRM has a better Quick ratio (0.92) than 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.92

4

3. Growth

3.1 Past

VRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2411.23%.
Looking at the last year, VRM shows a very negative growth in Revenue. The Revenue has decreased by -54.17% in the last year.
VRM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.87% yearly.
EPS 1Y (TTM)-2411.23%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-44826.16%
Revenue 1Y (TTM)-54.17%
Revenue growth 3Y-13.03%
Revenue growth 5Y0.87%
Revenue growth Q2Q12.72%

3.2 Future

The Earnings Per Share is expected to decrease by -2.45% on average over the next years.
The Revenue is expected to grow by 23.63% on average over the next years. This is a very strong growth
EPS Next Y2.7%
EPS Next 2Y-2.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year21.54%
Revenue Next 2Y23.63%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

VRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VRM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

VRM's earnings are expected to decrease with -2.45% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.45%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for VRM!.
Industry RankSector Rank
Dividend Yield N/A

VROOM INC

NASDAQ:VRM (5/3/2024, 7:25:17 PM)

Premarket: 13.5 +0.66 (+5.14%)

12.84

+0.35 (+2.8%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap22.98M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -24.77%
ROE -299.24%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 18.13%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 3.72
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.11
Quick Ratio 0.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-2411.23%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y2.7%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-54.17%
Revenue growth 3Y-13.03%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y